CETRORELIX ACETATE | N021197 | EMD SERONO INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Hyman, Phelps & McNamara, P.C. FDA-2024-P-2538 The law firm Hyman, Phelps & McNamara, P.C., submitted a suitability petition pursuant to Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act and 21 C.F.R. § 314.93 on behalf of a client requesting that the FDA declare Cetrorelix Acetate Injection 0.25 mg/mL pre-filled syringe suitable f | Suitability | 2024-05-24 | Open | Hyman |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.